Logo

aneuploidy

Venous Thromboembolism Risk Rise Reported in Individuals With Extra Sex Chromosomes

Researchers saw a significant uptick in VTE risk in individuals with supernumerary sex chromosome aneuploidies in both the Geisinger MyCode and UK Biobank cohorts.

Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment

Results from two new studies suggest that tumor aneuploidy can provide an additional layer of information to help predict response to checkpoint blockade immunotherapy.

Nanopore Sequencing Assay Enables Rapid Fetal Aneuploidy Detection
Premium

Researchers at Columbia University Irving Medical Center have developed a test that can detect aneuploidy in different types of reproductive samples within hours.

Devyser's Fetal Test Gains IVDR Certification

Devyser's QF-PCR-based test can be used by clinicians to detect aneuploidy in fetal cells circulating in maternal blood, amniotic fluid, and chorionic villus biopsy samples.

Low, Medium Levels of Mosaic Aneuploidy Among Embryos Don't Affect Birth Rates, Study Finds

An Igenomix-led team finds that low- or medium-grade mosaic embryos have similar birth and miscarriage rates as euploid embryos among IVF patients.

Feb 26, 2021

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year
Premium

Feb 25, 2021

Natera Revenues Grow 35 Percent in Q4

Jan 13, 2021

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

Dec 1, 2020

UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies

Nov 16, 2020

Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test
Premium

Nov 6, 2020

Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests
Premium

Oct 29, 2020

Humana Broadens Coverage of NIPT for Average Risk Pregnancies

Oct 26, 2020

Yourgene H1 Revenues Up 5 Percent

Sep 21, 2020

Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests

Sep 17, 2020

SVB Leerink Initiates Coverage of Natera With Outperform Rating

Aug 17, 2020

ACOG Guidelines Recommend NIPT for All Pregnancies Regardless of Risk

Aug 5, 2020

Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business

Jul 28, 2020

Yourgene Health Records £2.3M Net Loss for Fiscal Year 2020

Jul 13, 2020

Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

Jul 9, 2020

Aneuploidy Common in Early-Stage Human Embryos, Single-Cell RNA-Seq Study Reveals

Jul 7, 2020

Progenity Asks Court to Declare Non-Infringement of Natera Patents

Jun 3, 2020

Sperm Single-Cell Sequencing Study Offers Insight Into Meiotic Variation

May 12, 2020

Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal

May 6, 2020

Natera Q1 Revenues Grow 41 Percent

Apr 20, 2020

Yourgene Health Fiscal 2020 Revenues Up 86 Percent

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.